Arrhythmia Research Technology, Inc. Reports 2016 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Arrhythmia Research Technology (HRT) Reports Q2 EPS of $0.02
August 11, 2016 4:18 PM EDTArrhythmia Research Technology (NYSE: HRT) reported Q2 EPS of $0.02, versus $0.04 reported last year. Revenue for the quarter came in at $5.13 million, versus $5.66 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
... More